The evolving use of biologicals in the treatment and prevention of infectious diseases.
Although the studies presented in this symposium illustrate the benefits of biologicals in treating patients whose immune systems have been compromised by congenital or acquired immunodeficiencies, it is likely that in the future these agents will also play a role in the management of immunocompetent persons suffering from complications of infection. The insights resulting from the work discussed here provide a strong basis for making that possibility a reality.